BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16489507)

  • 1. Stability of Marek's disease virus 132-bp repeats during serial in vitro passages.
    Niikura M; Dodgson JB; Cheng HH
    Arch Virol; 2006 Jul; 151(7):1431-8. PubMed ID: 16489507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copy number of tandem direct repeats within the inverted repeats of Marek's disease virus DNA.
    Kanamori A; Nakajima K; Ikuta K; Ueda S; Kato S; Hirai K
    Biken J; 1986 Dec; 29(3-4):83-9. PubMed ID: 2441693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct evidence of host genome acquisition by the alphaherpesvirus Marek's disease virus.
    Niikura M; Dodgson J; Cheng H
    Arch Virol; 2006 Mar; 151(3):537-49. PubMed ID: 16155725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome analysis of Marek's disease virus strain CVI-988: effect of cell culture passage on the inverted repeat regions.
    van Iddekinge BJ; Stenzler L; Schat KA; Boerrigter H; Koch G
    Avian Dis; 1999; 43(2):182-8. PubMed ID: 10396630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic Marek's disease viruses lacking the 132 base pair repeats can still be attenuated by serial in vitro cell culture passages.
    Silva RF; Gimeno I
    Virus Genes; 2007 Jan; 34(1):87-90. PubMed ID: 16927124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that Marek's disease virus exists in a latent state in a sustainable fibroblast cell line.
    Abujoub AA; Coussens PM
    Virology; 1997 Mar; 229(2):309-21. PubMed ID: 9126245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of a unique region in the Marek's disease virus genome occurs concomitantly with attenuation but is not sufficient to cause attenuation.
    Silva RF; Reddy SM; Lupiani B
    J Virol; 2004 Jan; 78(2):733-40. PubMed ID: 14694105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCR detection of amplified 132 bp repeats in Marek's disease virus type 1 (MDV-1) DNA can serve as an indicator for critical genomic rearrangement leading to the attenuation of virus virulence.
    Becker Y; Tabor E; Asher Y; Davidson I; Malkinson M; Witter RL
    Virus Genes; 1993 Sep; 7(3):277-87. PubMed ID: 8279126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marek's disease virus (Kekava strain) replication in chickens, chick embryos and cell cultures.
    Yakovleva LS; Mazurenko NP; Gunenkova NK; Vinogradov VN; Pavlovskaya AI; Chernyakhovskaya IY
    Acta Virol; 1975 Jul; 19(4):293-8. PubMed ID: 241226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of pathogenic and non-pathogenic serotype 1 Marek's disease viruses (MDVs) by the polymerase chain reaction amplification of the tandem direct repeats within the MDV genome.
    Silva RF
    Avian Dis; 1992; 36(3):521-8. PubMed ID: 1329706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of a tandem direct repeat within inverted repeats of Marek's disease virus DNA during serial in vitro passage.
    Maotani K; Kanamori A; Ikuta K; Ueda S; Kato S; Hirai K
    J Virol; 1986 May; 58(2):657-60. PubMed ID: 3009876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative evaluation of viral fitness due to a single nucleotide polymorphism in the Marek's disease virus UL41 gene via an in vitro competition assay.
    Mao W; Niikura M; Silva RF; Cheng HH
    J Virol Methods; 2008 Mar; 148(1-2):125-31. PubMed ID: 18082901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of the glycoprotein C-negative phenotype of attenuated Marek's disease virus.
    Wilson MR; Southwick RA; Pulaski JT; Tieber VL; Hong Y; Coussens PM
    Virology; 1994 Mar; 199(2):393-402. PubMed ID: 7907196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The number of copies of an a-like region in the serotype-3 Marek's disease virus DNA genome is variable.
    Reilly JD; Silva RF
    Virology; 1993 Mar; 193(1):268-80. PubMed ID: 8382396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of oncogenic and nononcogenic strains of Marek's disease virus type 1 by using polymerase chain reaction DNA amplification.
    Zhu GS; Ojima T; Hironaka T; Ihara T; Mizukoshi N; Kato A; Ueda S; Hirai K
    Avian Dis; 1992; 36(3):637-45. PubMed ID: 1329711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of DNA from the cell-associated herpesvirus Marek's disease virus for 454 pyrosequencing using micrococcal nuclease digestion and polyethylene glycol precipitation.
    Volkening JD; Spatz SJ
    J Virol Methods; 2009 Apr; 157(1):55-61. PubMed ID: 19103224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of infectious Marek's disease virus genomes using pulsed field electrophoresis.
    Wilson MR; Coussens PM
    Virology; 1991 Dec; 185(2):673-80. PubMed ID: 1660199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrovirus insertion into herpesvirus: characterization of a Marek's disease virus harboring a solo LTR.
    Kost R; Jones D; Isfort R; Witter R; Kung HJ
    Virology; 1993 Jan; 192(1):161-9. PubMed ID: 8390750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replicating Marek's disease virus (MDV) serotype 2 DNA with inserted MDV serotype 1 DNA sequences in a Marek's disease lymphoblastoid cell line MSB1-41C.
    Hirai K; Yamada M; Arao Y; Kato S; Nii S
    Arch Virol; 1990; 114(3-4):153-65. PubMed ID: 2173523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic expansion of Marek's disease virus DNA is associated with serial in vitro passage.
    Silva RF; Witter RL
    J Virol; 1985 Jun; 54(3):690-6. PubMed ID: 2987523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.